Skip to content
healthcare.dev

nelarabine

NDC 81927-375, nelarabine, injection, from Shorla Oncology Inc..

Product NDC
81927-375
Status
Listed
Labeler
Shorla Oncology Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214809
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/81927-375 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NELARABINE5 mg/mL

Pharmacologic classes

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

Package NDCNDC-11Package
81927-375-01819270375011 VIAL, SINGLE-DOSE in 1 CARTON (81927-375-01) / 75 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/fc401b06-4e3b-413e-a854-3e031c433862

Use it

Look up 81927-375 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/81927-375 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 81927-375. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.